» Articles » PMID: 17955166

The Differential Diagnosis of Chronic Daily Headaches: an Algorithm-based Approach

Overview
Journal J Headache Pain
Publisher Biomed Central
Date 2007 Oct 24
PMID 17955166
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic daily headaches (CDHs) refers to primary headaches that happen on at least 15 days per month, for 4 or more hours per day, for at least three consecutive months. The differential diagnosis of CDHs is challenging and should proceed in an orderly fashion. The approach begins with a search for "red flags" that suggest the possibility of a secondary headache. If secondary headaches that mimic CDHs are excluded, either on clinical grounds or through investigation, the next step is to classify the headaches based on the duration of attacks. If the attacks last less than 4 hours per day, a trigeminal autonomic cephalalgia (TAC) is likely. TACs include episodic and chronic cluster headache, episodic and chronic paroxysmal hemicrania, SUNCT, and hypnic headache. If the duration is > or =4 h, a CDH is likely and the differential diagnosis encompasses chronic migraine, chronic tension-type headache, new daily persistent headache and hemicrania continua. The clinical approach to diagnosing CDH is the scope of this review.

Citing Articles

Temporomandibular disorders in migraine and tension-type headache patients: a systematic review with meta-analysis.

Bizzarri P, Manfredini D, Koutris M, Bartolini M, Buzzatti L, Bagnoli C J Oral Facial Pain Headache. 2025; 38(2):11-24.

PMID: 39801093 PMC: 11810655. DOI: 10.22514/jofph.2024.011.


New Daily Persistent Headache in the Pediatric and Adolescent Population: An Updated Review.

Kalika P, Monteith T Life (Basel). 2024; 14(6).

PMID: 38929707 PMC: 11204919. DOI: 10.3390/life14060724.


Advocacy for patients with headache disorders.

Gouider R, Lorenz D, Craven A, Grisold W, Dodick D eNeurologicalSci. 2023; 31:100466.

PMID: 37250108 PMC: 10209324. DOI: 10.1016/j.ensci.2023.100466.


Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial.

Hoydonckx Y, Singh M, Gilron I, Khan J, Narouze S, Dahan A Trials. 2023; 24(1):155.

PMID: 36855160 PMC: 9976458. DOI: 10.1186/s13063-023-07186-3.


Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial.

Ganji R, Majdinasab N, Hesam S, Rostami N, Sayyah M, Sahebnasagh A J Pharm Health Care Sci. 2021; 7(1):12.

PMID: 33789774 PMC: 8015063. DOI: 10.1186/s40780-021-00198-8.


References
1.
Scher A, Stewart W, Liberman J, Lipton R . Prevalence of frequent headache in a population sample. Headache. 2004; 38(7):497-506. DOI: 10.1046/j.1526-4610.1998.3807497.x. View

2.
Bigal M, Rapoport A, Sheftell F, Tepper S, Lipton R . The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic. Cephalalgia. 2007; 27(3):230-4. DOI: 10.1111/j.1468-2982.2006.01274.x. View

3.
Schwartz B, Stewart W, Simon D, Lipton R . Epidemiology of tension-type headache. JAMA. 1998; 279(5):381-3. DOI: 10.1001/jama.279.5.381. View

4.
Newman L, Lipton R, Solomon S . The hypnic headache syndrome: a benign headache disorder of the elderly. Neurology. 1990; 40(12):1904-5. DOI: 10.1212/wnl.40.12.1904-a. View

5.
Pareja J, Sjaastad O . SUNCT syndrome. A clinical review. Headache. 1997; 37(4):195-202. DOI: 10.1046/j.1526-4610.1997.3704195.x. View